Clinical Trial Update: An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

View source ↗

Summary

This clinical trial update examines predictors of response to letrozole 2.5 mg in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: University of Kansas | Conditions: Breast Cancer | Status: COMPLETED